![Eric Krauland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Eric M.
Krauland is President & Chief Scientific Officer at Adimab LLC since 2022.
Dr. Krauland holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from The Johns Hopkins University.
Postes actifs de Eric Krauland
| Sociétés | Poste | Début |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | President | 09/05/2022 |
Formation de Eric Krauland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
